Sage Journals: Discover world-class research

Retricted access

Research article

First published 2013-05

Long-term disease control with lapatinib and capecitabine in a patient with HER2-positive metastatic breast cancer pretreated with trastuzumab and trastuzumab-emtansine

Carmine De Angelis, Monica Milano, Piera Gargiulo [...]

Tumori Journal

Retricted access

Research article

First published 2014-11

Retreatment with Trastuzumab after Progression on Lapatinib-Based Therapy in Heavily Pretreated HER2-Positive Metastatic Breast Cancer: A Single-Institution Experience

Paolo Carli, Loredana Militello, Gian Maria Miolo [...]

Tumori Journal

Open access

Review article

First published 2012

Is the Improved Efficacy of Trastuzumab and Lapatinib Combination Worth the Added Toxicity? A Discussion of Current Evidence,Recommendations,and Ethical Issues regarding Dual HER2-Targeted Therapy

Eugene R. Ahn, Emilie Wang, Stefan Glück

Breast Cancer: Basic and Clinical Research

Open access

Case report

First published 2019-6

Dual-targeting strategy using trastuzumab and lapatinib in a patient with HER2 gene amplification in recurrent metachronous metastatic gallbladder carcinoma

Minfeng Ye, Jieqing Lv, Guangen Xu [...]

Journal of International Medical Research

Retricted access

Research article

First published 2014-2

Retrospective Study of the Prevalence,Predictors,and Consequences of Nonadherence With Lapatinib in Women With Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab

Thomas E. Delea, Alex Kartashov, Puza P. Sharma

Journal of Pharmacy Technology

Retricted access

Research article

First published 2013-11

Rapid tumor shrinkage with lapatinib plus capecitabine in a patient with massive liver involvement

Francesco Giotta, Agnese Latorre, Antonio Cramarossa [...]

Tumori Journal

Free access

Research article

First published 2009-11

Lapatinib in Metastatic Breast Cancer

J-S Frenel, E Bourbouloux, D Berton-Rigaud [...]

Women's Health

Retricted access

Research article

First published 2013-11

18 FDG-PET for Early Prediction of Complete Response to Lapatinib and Capecitabine in HER2-Positive Metastatic Breast Cancer: A Case Report

Ferdinando Riccardi, Carmela Mocerino, Carmela Barbato [...]

Tumori Journal

Free access

Research article

First published 2015-5

Lapatinib: An Oral Dual Tyrosine Kinase Inhibitor for HER-2-Positive Breast Cancer

Sagar D Sardesai, Anna Maria Storniolo

Women's Health

Open access

Research article

First published 2020

Dual HER2 Blockade in Neoadjuvant Treatment of HER2+ Breast Cancer: A Meta-Analysis and Review

Chaokun Wang, Jing Chen, Xiangyun Xu [...]

Technology in Cancer Research & Treatment

Search results